232 related articles for article (PubMed ID: 27804995)
1. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.
Ruiz P; Martin-Millan M; Gonzalez-Martin MC; Almeida M; González-Macias J; Ros MA
Sci Rep; 2016 Nov; 6():36201. PubMed ID: 27804995
[TBL] [Abstract][Full Text] [Related]
2. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
4. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
Sui X; Deng S; Liu M; Fan L; Wang Y; Xu H; Sun Y; Kishen A; Zhang Q
Cell Physiol Biochem; 2018; 48(5):2091-2102. PubMed ID: 30107384
[TBL] [Abstract][Full Text] [Related]
7. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse.
Sun W; Shi Y; Lee WC; Lee SY; Long F
Bone; 2016 Apr; 85():1-8. PubMed ID: 26780446
[TBL] [Abstract][Full Text] [Related]
8. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
9. Sfrp4 repression of the Ror2/Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption.
Chen K; Ng PY; Chen R; Hu D; Berry S; Baron R; Gori F
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14138-14143. PubMed ID: 31239337
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.
Stalvey MS; Clines KL; Havasi V; McKibbin CR; Dunn LK; Chung WJ; Clines GA
PLoS One; 2013; 8(11):e80098. PubMed ID: 24236172
[TBL] [Abstract][Full Text] [Related]
11. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
[TBL] [Abstract][Full Text] [Related]
12. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
13. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
14. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin.
Albers J; Keller J; Baranowsky A; Beil FT; Catala-Lehnen P; Schulze J; Amling M; Schinke T
J Cell Biol; 2013 Feb; 200(4):537-49. PubMed ID: 23401003
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
[TBL] [Abstract][Full Text] [Related]
16. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
17. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice.
Li J; Bao Q; Chen S; Liu H; Feng J; Qin H; Li A; Liu D; Shen Y; Zhao Y; Zong Z
J Orthop Res; 2017 Apr; 35(4):812-819. PubMed ID: 27306622
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bone metabolism by Wnt signals.
Kobayashi Y; Uehara S; Udagawa N; Takahashi N
J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
20. Roles of Wnt signals in bone resorption during physiological and pathological states.
Maeda K; Takahashi N; Kobayashi Y
J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
